Viewing Study NCT03258034


Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2026-01-07 @ 11:00 PM
Study NCT ID: NCT03258034
Status: UNKNOWN
Last Update Posted: 2017-08-22
First Post: 2017-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer
Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-08-24
Start Date Type: ESTIMATED
Primary Completion Date: 2020-08-22
Primary Completion Date Type: ESTIMATED
Completion Date: 2021-10-22
Completion Date Type: ESTIMATED
First Submit Date: 2017-08-20
First Submit QC Date: None
Study First Post Date: 2017-08-22
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-08-21
Last Update Post Date: 2017-08-22
Last Update Post Date Type: ACTUAL